Comparative effectiveness of two- and three-dose COVID-19 vaccination schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study

BACKGROUND: Kidney disease is a key risk factor for COVID-19-related mortality and suboptimal vaccine response. Optimising vaccination strategies is essential to reduce the disease burden in this vulnerable population. We therefore compared the effectiveness of two- and three-dose schedules involvin...

Descripción completa

Detalles Bibliográficos
Autores principales: Parker, Edward P.K., Horne, Elsie M.F., Hulme, William J., Tazare, John, Zheng, Bang, Carr, Edward J., Loud, Fiona, Lyon, Susan, Mahalingasivam, Viyaasan, MacKenna, Brian, Mehrkar, Amir, Scanlon, Miranda, Santhakumaran, Shalini, Steenkamp, Retha, Goldacre, Ben, Sterne, Jonathan A.C., Nitsch, Dorothea, Tomlinson, Laurie A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155829/
https://www.ncbi.nlm.nih.gov/pubmed/37363796
http://dx.doi.org/10.1016/j.lanepe.2023.100636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155829/
https://www.ncbi.nlm.nih.gov/pubmed/37363796
http://dx.doi.org/10.1016/j.lanepe.2023.100636

Ejemplares similares